These findings revealed that the Keap1/Nrf2 signaling pathway was significantly inhibited in T1DM-sensitive mice and suggested that inhibition of the Keap1/Nrf2 signaling pathway could be tightly associated with the progression of T1DM. Here, NFE2L2 is linked to type 1 diabetes mellitus.